WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
13.96 HKD
-4.12%
Market Closed
Updated:
May 4, 2024
WuXi Biologics (Cayman) Inc
Cash from Financing Activities
|
WuXi Biologics (Cayman) Inc
Cash from Financing Activities Peer Comparison
Comparables:
603259
300759
300347
1548
M
688114
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Financing Activities
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Financing Activities
¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Financing Activities
-¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Cash from Financing Activities
$1.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Financing Activities
¥3.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WuXi Biologics (Cayman) Inc's Cash from Financing Activities?
Cash from Financing Activities
-2.6B
CNY
-2.6B
CNY
Based on the financial report for Dec 31, 2023, WuXi Biologics (Cayman) Inc's Cash from Financing Activities amounts to -2.6B CNY.
What is WuXi Biologics (Cayman) Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
1%
1%
Over the last year, the Cash from Financing Activities growth was 1%.
You don't have any saved screeners yet
